E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/29/2016 in the Prospect News Emerging Markets Daily.

New Issue: India’s Piramal approves Rs. 1.05 billion of 9.383%, 9.57% debentures

By Tali Rackner

Norfolk, Va., June 29– Piramal Enterprises Ltd. informed the Bombay Stock Exchange that its board of directors approved the allotment of Rs. 1.05 billion of secured redeemable nonconvertible debentures.

The 1,050 debentures will be issued at a face value of Rs. 1 million each in two series: Series I has a tenor of 561 days and a coupon of 9.383%; and series II has a tenor of 1,093 days and a coupon of 9.57%.

The notes will be listed on the wholesale debt segment of the National Stock Exchange of India Ltd.

Piramal Enterprises, formerly Piramal Healthcare Ltd., is a Mumbai-based subsidiary of the Piramal Group.

Issuer:Piramal Enterprises Ltd.
Amount:Rs. 1.05 billion
Issue:Secured redeemable nonconvertible debentures
Maturity:Series I: 561 days; series II: 1,093 days
Coupon:Series I: 9.383%; series II: 9.57%
Pricing date:June 23

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.